Corvus Pharmaceuticals News

Corvus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Point72 Asset Management, L.P.(9.9%),Point72 Capital Advisors, Inc.(9.9%), etc.

May 10 05:33

Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Thompson Peter A.

May 9 08:35

Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director ORBIMED ADVISORS LLC

May 9 08:30

Corvus Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(11.1%),OrbiMed Capital GP V LLC(11.1%)

May 9 08:00

Corvus Pharmaceuticals | 10-Q: Quarterly report

May 8 05:22

Corvus Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 8 05:21

Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Jones William Benton

May 8 05:11

Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MILLER RICHARD A MD

May 8 05:11

Corvus Pharmaceuticals | 8-K: Current report

May 7 04:17

Corvus Pharmaceuticals | 8-K: Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results

May 7 04:07

Corvus Pharmaceuticals | 424B5: Prospectus

May 4 04:17

Corvus Pharmaceuticals | 8-K: Current report

May 2 05:12

Corvus Pharmaceuticals | DEFA14A: Others

Apr 27 04:19

Corvus Pharmaceuticals | DEF 14A: Definitive information statements

Apr 27 04:10

Corvus Pharmaceuticals | 10-K: Annual report

Mar 20 04:09

Corvus Pharmaceuticals | 8-K: Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 20 04:08

Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Arcara Jeffrey

Mar 2 07:00

Corvus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Samlyn Capital, LLC(5.1%),Samlyn, LP(5.1%), etc.

Feb 15 02:33

Corvus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard A. Miller(7.19%),Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985(3.04%), etc.

Feb 14 07:31

Corvus Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Arcara Jeffrey

Feb 9 05:32